Bachelor Thesis - DCF of biopharma firm (CELG) - No concrete research reports/sources for the forecast of the FCF available
Hello guys, I am a student from a European university. As part of my bachelor thesis I have to do a DCF analysis on a biopharma company (CELG). However, I have problems finding useful information to forecast the FCF; so far I only went through company filings and presentations.
I am looking for industry and equity research related to future cash flows. Through my uni I have access to Reuters EIKON and WRDS (Wharton Research). Unfortunately, I did not find any useful data regarding this there. I only found company snapchots on EBSCO by Acquis Data and MarketLine and one equity research report from CS from 2016 on Google.
My Questions: -Where do you find such data as a student? I am expected to write academically, which I find kind of hard as I have not a lot of information to base my assumptions on right now (and not academic sources).
-Into how much detail would you go for the FCF forecast (individual drug forecasts for the FCF, patent expirations, etc.)? I am still unsure on this as I have ~ 7 weeks for the thesis and still have to get an overview.
Would really appreciate it.
Thanks in advance.
Omnis aspernatur unde consequatur est tenetur quisquam repellat. Consequatur aut sit neque voluptas impedit tenetur. Qui adipisci molestias voluptas nostrum harum odit eum sit.
Neque facilis mollitia enim. Delectus rem maiores blanditiis. Ut quis nobis consequuntur blanditiis consequatur placeat consequatur et. Eligendi sequi iste aut nulla facere.
Et harum excepturi quidem aut. Quia corporis nostrum vel dolor sit eligendi. Excepturi velit accusantium provident dicta non sit facilis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...